Efficacy and safety of hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) on anemia in non-dialysis-dependent chronic kidney disease (NDD-CKD): a systematic review and meta-analysis

被引：0
|
作者：
Siliang Zhang
Jing Guo
Shuqin Xie
Jianwei Chen
Shenrun Yu
Yuan Yu
机构：
[1] Chongqing Medical University,Department of Nephrology, The Second Affiliated Hospital
[2] Chongqing University Cancer Hospital,Radiation Oncology Center
[3] Yongchuan People’s Hospital of Chongqing,Center of Urology and Nephrology
来源：
International Urology and Nephrology | 2021年 / 53卷
关键词：
Chronic kidney disease; Renal anemia; Hypoxia-inducible factor prolyl hydroxylase inhibitor; Meta-analysis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1139 / 1147
页数：8
相关论文
共 50 条
  • [1] Efficacy and safety of hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) on anemia in non-dialysis-dependent chronic kidney disease (NDD-CKD): a systematic review and meta-analysis
    Zhang, Siliang
    Guo, Jing
    Xie, Shuqin
    Chen, Jianwei
    Yu, Shenrun
    Yu, Yuan
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2021, 53 (06) : 1139 - 1147
  • [2] Safety and Efficacy of AND017, a Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (HIF-PHI), in Patients with Nondialysis-Dependent CKD (NDD-CKD)
    Zhu Yusha
    Zuo Li
    Ding Xiaoqiang
    Wilson, Suzanne
    Du Ping
    Zhu Qi
    Block, Geoffrey A.
    Pergola, Pablo E.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [3] Use of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor Agents for Anemia in Non-Dialysis-Dependent Chronic Kidney Disease: A Systematic Review and Meta-Analysis
    Eshaghpour, Ali
    Foote, Rachel
    Phillips, Anna
    Sreeraman, Shreyas
    Li, Allen
    Crowther, Mark
    BLOOD, 2022, 140 : 11045 - 11046
  • [4] Effectiveness of hypoxia-inducible factor prolyl hydroxylase inhibitor roxadustat on renal anemia in non-dialysis-dependent chronic kidney disease: a systematic review and meta-analysis
    Jia, Linpei
    Dong, Xingtong
    Yang, Jingyan
    Jia, Rufu
    Zhang, Hongliang
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (23)
  • [5] Effects of hypoxia-inducible factor prolyl hydroxylase inhibitors on iron regulation in non-dialysis-dependent chronic kidney disease patients with anemia: A systematic review and meta-analysis
    Li, Jing
    Xie, Qiong-Hong
    You, Li
    Xu, Ning-Xin
    Hao, Chuan-Ming
    PHARMACOLOGICAL RESEARCH, 2021, 163
  • [6] Investigational hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHI) for the treatment of anemia associated with chronic kidney disease
    Del Vecchio, Lucia
    Locatelli, Francesco
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2018, 27 (07) : 613 - 621
  • [7] AKB-6548, A NOVEL HYPOXIA-INDUCIBLE FACTOR PROLYL-HYDROXYLASE INHIBITOR (HIF-PHI) FOR THE TREATMENT OF ANEMIA IN PATIENTS WITH CHRONIC KIDNEY DISEASE NOT ON DIALYSIS (ND-CKD)
    Pergola, Pablo E.
    Spinowitz, Bruce
    Haase, Volker H.
    Hartman, Charlotte S.
    Farmer, Tasha M.
    Polu, Krishna R.
    Maroni, Bradley
    Shalwitz, Robert
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2015, 30
  • [8] A Prospective Single-Center Study on Desidustat, a Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (HIF-PHI), in the Management of Anemia in Dialysis-Dependent CKD
    Narayana, Kumar Arun
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024, 35 (10):
  • [9] An updated meta-analysis on the efficacy and safety of hypoxia-inducible factor prolyl hydroxylase inhibitor treatment of anemia in nondialysis-dependent chronic kidney disease
    Zhao, Hanxue
    Li, Peiyun
    Zhang, Hong-Liang
    Jia, Linpei
    RENAL FAILURE, 2023, 45 (02)
  • [10] Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors for Anemia in Non-Dialysis Dependent Chronic Kidney Disease: Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Tyagi, Jyoti
    Kaur, Manveen
    Moola, Sandeep
    Ramachandran, Raja
    Meena, Priti
    Bajpai, Divya
    Bhaumik, Soumyadeep
    INDIAN JOURNAL OF NEPHROLOGY, 2025, 35 (02) : 217 - 233
12345